Sort
46,585 grants matching “heart failure”
Aldosterone Synthase & Hypertension
$632,402Ashok Kumar Kumar · New York Medical College · R01 · FY2017 · HL
Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)
$632,386Marcelo F Di Carli · Brigham And Women'S Hospital · R01 · FY2017 · HL
Functional Microdomains in the Heart's Pacemaker: A New Dimension of Cardiac Remodeling
$632,382Alexey V Glukhov · University Of Wisconsin-Madison · R01 · FY2024 · HL
Improving Hypertension Medication Adherence for Older Adults
$632,347Jeannie Kim Lee · University Of Arizona · R01 · FY2023 · NR
Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiology
$632,301Alexander Egbe · Mayo Clinic Rochester · R01 · FY2022 · HL
Individualized medicine to predict and prevent chemotherapy-related heart failure
$632,207Nadine Norton · Mayo Clinic Jacksonville · R01 · FY2024 · HL
Mechanisms of cardiac sympathetic hyperactivity in chronic heart failure
$632,166Yu-Long Li · University Of Nebraska Medical Center · R01 · FY2024 · HL
Reducing the risk of chronic hypertension and improving vascular function following preeclampsia
$632,110Anna Palatnik · Medical College Of Wisconsin · R01 · FY2024 · HD
Global Cardiovascular Disease Policy Model for Screening Prevention and Treatment
$632,073Thomas A Gaziano · Harvard School Of Public Health · R01 · FY2012 · HL
Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor
$632,028John Andrew Kalapurakal · Northwestern University At Chicago · R01 · FY2017 · CA
Predicting and preventing drug metabolism by the human gut microbiome
$631,994Peter James Turnbaugh · University Of California, San Francisco · R01 · FY2024 · HL
STOP-CA: Statins to prevent Cardiotoxicity from Anthracyclines
$631,959Tomas G Neilan · Massachusetts General Hospital · R01 · FY2020 · HL
Effect of Cardioplegia and Cardiopulmonary Bypass on Coronary Microvascular Reactivity
$631,958Frank W Sellke · Rhode Island Hospital · R01 · FY2020 · HL
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
$631,925Margaret Leighton McNairy · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · HL
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
$631,925Margaret Leighton McNairy · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · HL
High-Intensity Ultrasound Ablation for Septal Reduction Therapy of Hypertrophic Cardiomyopathy
$631,913Babak Nazer · University Of Washington · R01 · FY2025 · HL
Adverse pregnancy outcomes and long-term risk of cardiovascular disease in women
$631,897Casey Crump · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · HL
3D Echocardiography to Improve Clinical Outcomes After Surgery for Ischemic Mitral Regurgitation
$631,855Robert C Gorman · University Of Pennsylvania · R01 · FY2020 · HL
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure
$631,842Laurence J Miller · Mayo Clinic Arizona · R01 · FY2024 · HL
Cardioprotective Effect of Growth Hormone Releasing Hormone
$631,836Joshua M Hare · University Of Miami School Of Medicine · R01 · FY2015 · HL
Center for American Indian and Alaska Native Diabetes Translational Research
$631,814Spero M Manson · University Of Colorado Denver · P30 · FY2015 · DK
Trajectories of Serious Illness: Patients and Caregivers
$631,795Duke University · R01 · FY2005 · NR
Subclinical Atherosclerosis in HIV plus Black Cocaine Users
$631,783Shenghan Lai · Johns Hopkins University · R01 · FY2013 · DA
Integrative genomic and transcriptomic investigation of human heart failure mechanisms
$631,780Matthew R Taylor · University Of Colorado Denver · R01 · FY2025 · HL
Regulation of a cardiac b1AR/SERCA2 complex in heart failure
$631,690Yang K Xiang · University Of California At Davis · R01 · FY2023 · HL